Powered by RND

Joint Action

David Hunter, PhD, FRACP (Rheum)
Joint Action
Latest episode

Available Episodes

5 of 155
  • World Arthritis Day 2025
    Did you know that 1 in 8 Australians live with osteoarthritis? It is one of the leading causes of pain and disability worldwide. On this special episode, we hear from previous guests on common misconceptions and beliefs about osteoarthritis, the importance of staying physically active, behaviour change, and driving change in osteoarthritis.If you are interested, you can listen to the full episodes:“Common Misconceptions and Beliefs about Osteoarthritis” with A/Prof Ben Darlow (Season 6, Ep. 16)“Walking for Joint Health” with Dr Sarah Kobayashi (Season 6, Ep. 12)"Tips for behaviour change for diet and exercise" with Dr Shannon Mihalko (Season 4, Ep. 1)"Driving change in osteoarthritis - strategies, barriers and consumer power" with Louise Hardy (Season 6, Ep. 7)RESOURCESMyOA.org.au - Additional resourcesCONNECT WITH USJoin one of our trials https://www.osteoarthritisresearch.com.au/current-trialsInstagram: @profdavidhunterTwitter: @ProfDavidHunter @jointactionorgEmail: [email protected]: www.jointaction.info/podcastIf you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review! Hosted on Acast. See acast.com/privacy for more information.
    --------  
    27:20
  • Can knee realignment slow down osteoarthritis? A discussion with Dr Trevor Birmingham and Dr David Parker
    High tibial osteotomy (HTO) is a limb realignment surgery which is intended for people who have medial compartment osteoarthritis (OA), but are not suitable candidates for total knee replacement due to younger age, less severe disease and greater physical demands. The aim of HTO is to correct alignment, thereby shifting load away from the more involved knee compartment and limit progression of knee OA.On this week's episode of Joint Action, we are joined by Dr Trevor Birmingham and Dr David Parker to discuss high tibial osteotomy surgery, who it is suitable for and the risks involved.Professor Trevor Birmingham is a physiotherapist and Canada Research Chair in Musculoskeletal Rehabilitation at the University of Western Ontario in London, Canada. He leads research on musculoskeletal health, often combining clinical outcomes with biomechanical, imaging and biological measures in cohort studies and randomized trials. He co-directs the Wolf Orthopaedic Biomechanics Lab at the Fowler Kennedy Sport Medicine Clinic and is a founding member of the Bone and Joint Institute and the Collaborative Graduate Training Program in Musculoskeletal Health Research at Western University. Dr David Parker is an experienced orthopaedic knee specialist and co-founder of the Sydney Orthopaedic Research Institute (SORI). He is passionate about sport and is actively involved with international orthopaedic and sports medicine organisations and has extensive experience with athletes of all levels from recreational to elite. Dr Parker has authored over 100 peer-reviewed publications and many textbook chapters and has been awarded the Australian Orthopaedic Association Prize for Research. RESOURCESJournal articlesTotal knee replacement after high tibial osteotomy: time-to-event analysis and predictorsCONNECT WITH USJoin one of our trials https://www.osteoarthritisresearch.com.au/current-trialsTwitter: @ProfDavidHunter @jointactionorgEmail: [email protected]: www.jointaction.info/podcastIf you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review! Hosted on Acast. See acast.com/privacy for more information.
    --------  
    28:19
  • In Memoriam: Prof Frank Beier - new insights into osteoarthritis onset (2021)
    This week's episode is in honour of Frank Beier, who recently passed away on July 18, 2025. Frank leaves behind a remarkable legacy through the impact he made in the field of osteoarthritis. In this previous episode (2021), he discussed the recent advances in osteoarthritis understanding with a particular emphasis on novel targets and epigenetics.Despite the large prevalence of osteoarthritis, there is no clinically approved drug which provides a cure. Currently, drugs focus on relieving symptoms such as pain. Experiments done in the laboratory have provided insight on osteoarthritis onset and progression and will likely guide therapeutic development. We know that osteoarthritis is a disease of the whole organ meaning that any of the tissues involved in the synovial joint can be affected. The interplay between the various cell types involved is complex and understanding the interactions between cartilage, bone and synovium may be critical to therapeutic development. Skeletal development likely plays a very important role in predisposition to disease. Through the identification of serious pathologies such as various forms of dwarfism (what in medical terms are called chondrodysplasias) the role of transcription factors and epigenetics is increasing our understanding of disease genesis.The study of the epigenetics of OA - the mechanism by which the human genome alters it’s gene expression (without changing the primary DNA sequence) has provided valuable information on novel risk factors for the disease and are potential therapeutic targets for OA.RESOURCESJournal articlesNuclear receptors as potential drug targets in osteoarthritisInterplay between genetics and epigenetics in osteoarthritisRecent developments in emerging therapeutic targets of osteoarthritisCONNECT WITH USTwitter: @ProfDavidHunter @jointactionorgEmail: [email protected]: www.jointaction.info/podcastIf you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review! Hosted on Acast. See acast.com/privacy for more information.
    --------  
    29:26
  • Food for thought – the link between UPFs and knee osteoarthritis with Dr Gabby Joseph
    On this week's episode of Joint Action discover how ultra-processed foods may be silently contributing to osteoarthritis. Dr Gabby Joseph joins us to discuss her research research linking poor diet quality to greater knee pain, poorer physical function and thinner knee cartilage. Dr Gabby Joseph is a scientist and statistician with over 20 years of experience leading research funded by the US government at the University of California San Francisco, Her work focuses on musculoskeletal imaging, predictive modelling, and clinical study design, with a focus on applying advanced statistical and machine learning methods to improve patient outcomes She is the co-Director of The University of California's Clinical & Translational Musculoskeletal Imaging group and passionate about making sense of complex data so that it can be used to improve real-world care. RESOURCESUltra-processed food consumption is associated with knee osteoarthritis: Data from the Osteoarthritis InitiativeCONNECT WITH USTwitter: @ProfDavidHunter @jointactionorgInstagram: @osteoarthritisresearchgroupEmail: [email protected]: www.jointaction.info/podcast Hosted on Acast. See acast.com/privacy for more information.
    --------  
    29:10
  • From court to classroom: Dr John Drazan’s game plan for STEM education
    Dribbling into discovery - on this episode of Joint Action, we are joined by Dr John Drazan to learn more about how he is using basketball to inspire the next generation of scientists. Dr John Drazan is an Assistant Professor of biomedical engineering at Fairfield University where he studies the relationship between muscle structure and function to understand how muscles remodel in response to aging, injury, or training. He is an award-winning STEM educator and former collegiate basketball player who runs STEM focused clinics to encourage student interest in maths, science, technology and engineering. His innovative programs have reached over 25,000 students across the USA.CONNECT WITH USTwitter: @ProfDavidHunter @jointactionorgInstagram: @osteoarthritisresearchgroupEmail: [email protected]: www.jointaction.info/podcastIf you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review! Hosted on Acast. See acast.com/privacy for more information.
    --------  
    24:55

More Health & Wellness podcasts

About Joint Action

Joint Action is a podcast hosted by David Hunter.As a consequence of isolation, those living with osteoarthritis related disability may become less fit, more depressed and anxious, more socially isolated and gain weight. It is critical at times like this that people with osteoarthritis have their burden and disability minimised and their knowledge of how to manage the disease enhanced. Join David as he interviews the world's leading experts in osteoarthritis.Professor David Hunter is a rheumatology clinician researcher whose main research focus has been clinical and translational research in osteoarthritis. He is the Florance and Cope Chair of Rheumatology and Professor of Medicine at University of Sydney and the Royal North Shore Hospital, Sydney, Australia. He is ranked as the worlds leading expert in osteoarthritis on Expertscape.com since 2014.​You can send in your questions to [email protected] and follow us on Twitter @jointactionorg and @ProfDavidHunter Hosted on Acast. See acast.com/privacy for more information.
Podcast website

Listen to Joint Action, What's That Rash? and many other podcasts from around the world with the radio.net app

Get the free radio.net app

  • Stations and podcasts to bookmark
  • Stream via Wi-Fi or Bluetooth
  • Supports Carplay & Android Auto
  • Many other app features
Social
v7.23.9 | © 2007-2025 radio.de GmbH
Generated: 10/17/2025 - 5:24:46 AM